The Competition Commission of India (CCI) has given its nod for acquisition of majority shareholding of Glenmark Life Sciences Limited by Nirma Ltd.

CCI approves acquisition of majority shareholding of the Glenmark Life Sciences Ltd by the Nirma Ltd”, said a CCI post in platform ‘X’, which was formerly known as Twitter. In September this year, Nirma had announced that it would acquire 75 per cent stake in Glenmark Life Sciences for ₹7,500 crore. Glenmark Pharmaceuticals had decided to sell the 75 per cent stake to retire outstanding debt of ₹4,340 crore.

      The Competition Commission of India (CCI) has given its nod for acquisition of majority shareholding of Glenmark Life Sciences Limited by Nirma Ltd.

      CCI Approves Nirma’s Majority Stake Buy in Glenmark Life Sciences

      Also approves acquisition of certain business undertakings of Ind Swift Laboratories by Synthimed Labs

About CCI (Competition Commission of India):